This subtype prediction tool was developed using a variety of data sources, including a thorough review of the medical literature on clinical presentations and diagnostic findings for various forms of LGMD, and consultation with diagnostic pathologists and clinical neurologists who specialize in research and diagnosis of muscular dystrophy.